NCAM1 and neurodegenerative disease: Recent reports have revealed that the PSA-NCAM complex is decreased in the brains of diseased humans and rodents (Varea et al., 2005; Murray et al., 2016), and modified PSA-NCAM complexes can be seen in several neurodegenerative diseases such as AD and PD (Murray et al., 2016).